XML 23 R13.htm IDEA: XBRL DOCUMENT v3.10.0.1
Note 7 - Fair Value Measurement
9 Months Ended
Sep. 30, 2018
Notes to Financial Statements  
Fair Value Disclosures [Text Block]
Note
7.
Fair Value Measurement
 
The Company uses a hierarchy of valuation techniques based on whether the inputs to those valuation techniques are observable or unobservable. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect the Company’s market assumptions. The
three
levels of the fair value hierarchy based on these
two
types of inputs are as follows:
 
Level
1
- Valuation is based on quoted prices in active markets for identical assets and liabilities.
 
Level
2
- Valuation is based on observable inputs including quoted prices in active markets for similar assets and liabilities, quoted prices for identical or similar assets and liabilities in less active markets, and model-based valuation techniques for which significant assumptions can be derived primarily from or corroborated by observable data in the market.
 
Level
3
- Valuation is based on model-based techniques that use
one
or more significant inputs or assumptions that are unobservable in the market.
 
The following describes the valuation techniques used by the Company to measure certain financial assets and liabilities recorded at fair value on a recurring basis in the consolidated financial statements:
 
Securities available for sale:
Securities available for sale are recorded at fair value on a recurring basis. Fair value measurement is based upon quoted market prices, when available (Level
1
). If quoted market prices are
not
available, fair values are measured utilizing independent valuation techniques of identical or similar securities for which significant assumptions are derived primarily from or corroborated by observable market data. Third party vendors compile prices from various sources and
may
determine the fair value of identical or similar securities by using pricing models that consider observable market data (Level
2
).
 
The following tables present the balances of financial assets and liabilities measured at fair value on a recurring basis as of
September 30, 2018
and
December 31, 2017:
 
(Dollars in Thousands)
         
Carrying value at September 30, 2018
 
Description
 
Balance as of
September 30,
2018
   
Quoted
Prices
in Active
Markets for
Identical
Assets
(Level 1)
   
Significant
Other
Observable
Inputs
(Level 2)
   
Significant
Unobservable
Inputs
(Level 3)
 
Assets:
                               
U.S. Government agency securities
  $
10,800
    $     $
10,800
    $  
Mortgage-backed securities and CMO’s
   
19,325
           
19,325
       
Corporate securities
   
6,588
           
6,588
       
Municipal securities
   
8,991
           
8,991
       
 
(Dollars in Thousands)
         
Carrying value at December 31, 2017
 
Description
 
Balance as of
December 31,
2017
   
Quoted
Prices
in Active
Markets for
Identical
Assets
(Level 1)
   
Significant
Other
Observable
Inputs
(Level 2)
   
Significant
Unobservable
Inputs
(Level 3)
 
Assets:
                               
U.S. Government agency securities
  $
13,435
    $     $
13,435
    $  
Mortgage-backed securities and CMO’s
   
23,981
           
23,981
       
Corporate securities
   
7,067
           
7,067
       
Municipal securities
   
10,861
           
10,861
       
 
Certain assets are measured at fair value on a nonrecurring basis in accordance with generally accepted accounting principles (GAAP). Adjustments to the fair value of these assets usually result from the application of lower-of-cost-or-market accounting or write-downs of individual assets.
 
The following describes the valuation techniques used by the Company to measure certain assets recorded at fair value on a nonrecurring basis in the consolidated financial statements:
 
Impaired Loans:
The Company does
not
record loans at fair value on a recurring basis. However, from time to time a loan is considered impaired and a specific reserve is established. Loans for which it is probable that payment of interest and principal will
not
be made in accordance with the contractual terms of the loan agreement are considered impaired. Once a loan is identified as individually impaired, management measures the extent of any loss. The fair value of impaired loans is estimated using
one
of several methods, including collateral value, market value, and discounted cash flow. Those impaired loans
not
requiring an allowance represent loans for which the fair value of the expected repayments or collateral exceed the recorded investment in such loans. Impaired loans where an allowance is established based on the fair value of collateral require classification in the fair value hierarchy. If carried at market price based on appraised value less selling costs using observable market data, it is recorded as nonrecurring Level
2.
When an appraised value is
not
available or management determines the fair value of the collateral is further impaired below the appraisal value and there is
no
observable market price, the Company records the impaired loan as nonrecurring Level
3.
 
 
Loans held for sale:
The carrying value of these loans approximates the fair value. These loans close in the name of the Bank’s consolidated joint venture subsidiary HomeTown Residential Mortgage, LLC, but are generally sold within a
two
-week period.
 
Other Real Estate Owned (OREO)
: The carrying amount of real estate owned by the Company resulting from foreclosures is estimated at the lesser of cost or the fair value of the real estate based on an observable market price or a current appraised value less selling costs. If carried at market price based on appraised value using observable market data, it is recorded as nonrecurring Level
2.
When an appraised value is
not
available or is
not
current, or management determines the fair value of the real estate is further impaired below the appraised value or there is
no
observable market price, the Company records the real estate as nonrecurring Level
3.
 
The following tables summarize the Company’s assets that were measured at fair value on a nonrecurring basis as of
September 30, 2018
and
December 31, 2017.
 
(Dollars in Thousands)
         
Carrying value at September 30, 2018
 
Description
 
Balance as
of
September 30,
2018
   
Quoted
Prices
in Active
Markets
for Identical
Assets
(Level 1)
   
Significant
Other
Observable
Inputs
(Level 2)
   
Significant
Unobservable
Inputs
(Level 3)
 
Assets:
                               
Loans held for sale
  $
1,378
    $     $
1,378
    $
 
Other real estate owned
   
3,196
           
697
     
2,499
 
 
(Dollars in Thousands)
         
Carrying value at December 31, 2017
 
Description
 
Balance as
of
December 31,
2017
   
Quoted
Prices
in Active
Markets
for Identical
Assets
(Level 1)
   
Significant
Other
Observable
Inputs
(Level 2)
   
Significant
Unobservable
Inputs
(Level 3)
 
Assets:
                               
Loans held for sale
  $
1,587
    $     $
1,587
    $
 
Other real estate owned
   
3,249
           
     
3,249
 
 
At
September 30, 2018
and
December 31, 2017,
the Company did
not
have any liabilities measured at fair value on a nonrecurring basis.
 
The following table displays quantitative information about Level
3
Fair Value Measurements for
September 30, 2018:
 
(Dollars in Thousands)
 
Quantitative information about Level 3 Fair Value Measurements for September 30, 2018
 
Assets
 
Fair
Value
 
 
Valuation Technique(s)
 
 
Unobservable input
 
Range
(Weighted Average)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Other real estate owned
 
$
1,922
 
 
Discounted appraised value
 
 
Selling cost
 
6%
-
10%
(8%)
 
 
 
 
 
 
 
 
 
 
Discount for lack of marketability and age of appraisal
 
0%
-
10%
(0%)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
$
577
 
 
Internal evaluations
 
 
Internal evaluations
 
29%
-
29%
(29%)
 
 
The following table displays quantitative information about Level
3
Fair Value Measurements for
December 31, 2017:
 
(Dollars in Thousands)
 
Quantitative information about Level 3 Fair Value Measurements for December 31, 2017
 
Assets
 
Fair
Value
 
 
Valuation Technique(s)
 
 
Unobservable input
 
Range
(Weighted Average)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Other real estate owned
 
$
2,254
 
 
Discounted appraised value
 
 
Selling cost
 
6%
-
10%
(8%)
 
 
 
 
 
 
 
 
 
 
Discount for lack of marketability and age of appraisal
 
0%
-
43%
(7%)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
$
995
 
 
Internal evaluations
 
 
Internal evaluations
 
19%
-
19%
(19%)
 
 
 
The following tables summarize the estimated fair values of the Company’s financial instruments at 
September 30, 2018 
and at 
December 31, 2017. 
The Company discloses fair value information about financial instruments, whether or 
not
recognized in the statements of financial condition, for which it is practicable to estimate that value. The following estimated fair value amounts have been determined using available market information and appropriate valuation methodologies. However, management judgment is required to interpret data and develop fair value estimates. Accordingly, the estimates below are 
not
 necessarily indicative of the amounts the Company could realize in a current market exchange. The use of different market assumptions and/or estimation methodologies 
may 
have a material effect on the estimated fair value amounts.
 
During the
first
quarter of
2018,
the Company adopted ASU 
2016
-
01
 Financial Instruments – Overall (Subtopic 
825
-
10
): “Recognition and Measurement of Financial Assets and Financial Liabilities”, which among other things, requires a public business entity to base their fair value disclosures for financial instruments that are 
not
 measured at fair value in the financial statements on the exit price notion. In accordance with this guidance, the Company has adopted the exit price disclosure requirements for the below table on a prospective basis for the period ended 
September 30, 2018. 
The disclosure included for the period ended 
December 31, 2017 
continues to be presented utilizing the entry price assumption previously utilized.
 
Carrying amount and estimated fair values of financial instruments were as follows for the periods indicated:
 
(Dollars in Thousands)
         
Fair value at September 30, 2018
 
Description
 
Carrying
value as of
September 30,
2018
   
Quoted
Prices
in Active
Markets for
Identical
Assets
(Level 1)
   
Significant
Other
Observable
Inputs
(Level 2)
   
Significant
Unobservable
Inputs
(Level 3)
   
Approximate
Fair Values
 
Financial assets
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cash and due from banks
  $
18,126
    $
18,126
    $
    $
    $
18,126
 
Federal funds sold
   
193
     
193
     
     
     
193
 
Securities available for sale
   
45,704
     
     
45,704
     
     
45,704
 
Restricted equity securities
   
2,359
     
     
2,359
     
     
2,359
 
Loans held for sale
   
1,378
     
     
1,378
     
     
1,378
 
Loans, net
   
462,396
     
     
     
453,266
     
453,266
 
Bank owned life insurance
   
8,147
     
     
8,147
     
     
8,147
 
Accrued income
   
2,639
     
     
2,639
     
     
2,639
 
Financial liabilities
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Total deposits
   
483,497
     
     
483,157
     
     
483,157
 
FHLB borrowings
   
10,728
     
     
10,710
     
     
10,710
 
Subordinated notes
   
7,277
     
     
7,622
     
     
7,622
 
Other borrowings
   
1,348
     
     
1,348
     
     
1,348
 
Accrued interest payable
   
556
     
     
556
     
     
556
 
 
The carrying amounts and approximate fair values of the Company's financial instruments are as follows at
December 31, 2017:
 
(Dollars in Thousands)
         
Fair value at December 31, 2017
 
Description
 
Carrying
value as of
December 31,
2017
   
Quoted
Prices
in Active
Markets for
Identical
Assets
(Level 1)
   
Significant
Other
Observable
Inputs
(Level 2)
   
Significant
Unobservable
Inputs
(Level 3)
   
Approximate
Fair Values
 
Financial assets
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cash and due from banks
  $
21,714
    $
21,714
    $
    $
    $
21,714
 
Federal funds sold
   
180
     
180
     
     
     
180
 
Securities available for sale
   
55,344
     
     
55,344
     
     
55,344
 
Restricted equity securities
   
2,371
     
     
2,371
     
     
2,371
 
Loans held for sale
   
1,587
     
     
1,587
     
     
1,587
 
Loans, net
   
440,437
     
     
     
438,449
     
438,449
 
Bank owned life insurance
   
8,669
     
     
8,669
     
     
8,669
 
Accrued income
   
2,681
     
     
2,681
     
     
2,681
 
Financial liabilities
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Total deposits
   
477,320
     
     
477,599
     
     
477,599
 
FHLB borrowings
   
11,028
     
     
11,150
     
     
11,150
 
Subordinated notes
   
7,254
     
     
7,890
     
     
7,890
 
Other borrowings
   
1,558
     
     
1,558
     
     
1,558
 
Accrued interest payable
   
368
     
     
368
     
     
368